OASMY
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Jun 11 closing price
Capitalization
12.82M
37 days until earnings call
PCLOF
Price
$0.05
Change
+$0.01 (+25.00%)
Updated
Jul 3 closing price
Capitalization
17.67M
Interact to see
Advertisement

OASMY vs PCLOF

Header iconOASMY vs PCLOF Comparison
Open Charts OASMY vs PCLOFBanner chart's image
VIVESTO AB
Price$0.02
Change-$0.00 (-0.00%)
Volume$900
Capitalization12.82M
PHARMACIELO
Price$0.05
Change+$0.01 (+25.00%)
Volume$18.04K
Capitalization17.67M
OASMY vs PCLOF Comparison Chart in %
Loading...
OASMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OASMY vs. PCLOF commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OASMY is a Hold and PCLOF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (OASMY: $0.02 vs. PCLOF: $0.05)
Brand notoriety: OASMY and PCLOF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: OASMY: 238% vs. PCLOF: 294%
Market capitalization -- OASMY: $12.82M vs. PCLOF: $17.67M
OASMY [@Pharmaceuticals: Other] is valued at $12.82M. PCLOF’s [@Pharmaceuticals: Other] market capitalization is $17.67M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OASMY’s FA Score shows that 0 FA rating(s) are green whilePCLOF’s FA Score has 0 green FA rating(s).

  • OASMY’s FA Score: 0 green, 5 red.
  • PCLOF’s FA Score: 0 green, 5 red.
According to our system of comparison, PCLOF is a better buy in the long-term than OASMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OASMY’s TA Score shows that 2 TA indicator(s) are bullish while PCLOF’s TA Score has 7 bullish TA indicator(s).

  • OASMY’s TA Score: 2 bullish, 0 bearish.
  • PCLOF’s TA Score: 7 bullish, 1 bearish.
According to our system of comparison, PCLOF is a better buy in the short-term than OASMY.

Price Growth

OASMY (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while PCLOF (@Pharmaceuticals: Other) price change was +2.93% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

OASMY is expected to report earnings on Aug 12, 2025.

PCLOF is expected to report earnings on Feb 28, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCLOF($17.7M) has a higher market cap than OASMY($12.8M). PCLOF YTD gains are higher at: -5.646 vs. OASMY (-50.000). PCLOF has higher annual earnings (EBITDA): -11.6M vs. OASMY (-88.39M). OASMY has more cash in the bank: 119M vs. PCLOF (461K). OASMY has less debt than PCLOF: OASMY (7.89M) vs PCLOF (14.3M). PCLOF has higher revenues than OASMY: PCLOF (4.89M) vs OASMY (1.02M).
OASMYPCLOFOASMY / PCLOF
Capitalization12.8M17.7M72%
EBITDA-88.39M-11.6M762%
Gain YTD-50.000-5.646886%
P/E RatioN/AN/A-
Revenue1.02M4.89M21%
Total Cash119M461K25,813%
Total Debt7.89M14.3M55%
FUNDAMENTALS RATINGS
OASMY vs PCLOF: Fundamental Ratings
OASMY
PCLOF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
8559
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PCLOF's Valuation (54) in the null industry is in the same range as OASMY (79). This means that PCLOF’s stock grew similarly to OASMY’s over the last 12 months.

PCLOF's Profit vs Risk Rating (100) in the null industry is in the same range as OASMY (100). This means that PCLOF’s stock grew similarly to OASMY’s over the last 12 months.

OASMY's SMR Rating (94) in the null industry is in the same range as PCLOF (99). This means that OASMY’s stock grew similarly to PCLOF’s over the last 12 months.

PCLOF's Price Growth Rating (59) in the null industry is in the same range as OASMY (85). This means that PCLOF’s stock grew similarly to OASMY’s over the last 12 months.

PCLOF's P/E Growth Rating (100) in the null industry is in the same range as OASMY (100). This means that PCLOF’s stock grew similarly to OASMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OASMYPCLOF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
23%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
14%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OASMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OUKPY6.550.01
+0.17%
Metso OYJ
AAMMF0.24N/A
N/A
Almadex Minerals Ltd.
CMGMF7.76N/A
N/A
Chemring Group Plc.
GENTF11.15N/A
N/A
G5 Entertainment AB
SBNYL3.75-0.05
-1.32%
Signature Bank (New York, NY)

OASMY and

Correlation & Price change

A.I.dvisor tells us that OASMY and MVMDF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OASMY and MVMDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OASMY
1D Price
Change %
OASMY100%
N/A
MVMDF - OASMY
9%
Poorly correlated
-5.04%
MKGAF - OASMY
4%
Poorly correlated
+0.12%
PCLOF - OASMY
2%
Poorly correlated
+37.05%
NDVAF - OASMY
2%
Poorly correlated
N/A
OMID - OASMY
2%
Poorly correlated
N/A
More

PCLOF and

Correlation & Price change

A.I.dvisor tells us that PCLOF and OWPC have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCLOF and OWPC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCLOF
1D Price
Change %
PCLOF100%
+37.05%
OWPC - PCLOF
8%
Poorly correlated
+2.62%
PHCUF - PCLOF
7%
Poorly correlated
N/A
RGEDF - PCLOF
5%
Poorly correlated
N/A
OVATF - PCLOF
4%
Poorly correlated
-13.28%
ROMJF - PCLOF
3%
Poorly correlated
+4.20%
More